Tag: SITC
MaaT Pharma announces poster presentation at the 38th annual conference of the Society for Immunotherapy of Cancer (SITC) – 09/27/2023 at 6:17 p.m.
Lyon, France, September 27, 2023 – 6:00 p.m. CET – MaaT Pharma (EURONEXT: MAAT – the “Company”), an advanced clinical-stage biotechnology company, leader in the development of Microbiome Ecosystem TherapiesTM…
OSE Immunotherapeutics presents advances in its research programs at upcoming international conferences CICON International Conference (Cancer Immunotherapy Conference) SITC Congress (Society for Immunotherapy of Cancer) PEGS Europe (Protein & Antibody Engineering Summit) – 09/20/2023 at 07 :30
Nantes, France – September 20, 2023, 7:30 a.m. – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) announces that the scientific advances from its research programs have been selected for presentation…
SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 37TH ANNUAL MEETING: NANOBIOTIX PRESENTS UPDATED PHASE 1 DATA ON COMBINATION OF NBTXR3 WITH ANTI-PD-1, WHICH MAY SUPPORT RADIOENHANCER’S IMMUNE SYSTEM-BOOSTING POTENTIAL – 10 /11/2022 at 08:30
These data will be discussed during the conference call presenting Nanobiotix’s third quarter results, at 8 a.m. EST / 2 p.m. CET. • Data from the entire dose escalation part…